Literature DB >> 1464160

Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.

G Powis1, M J Seewald, D Melder, M Hoke, C Gratas, T A Christensen, D E Chapman.   

Abstract

The ability of the polysulfonated antitumor drug suramin and six related polysulfonated azo dyes to inhibit the cell growth, platelet-derived growth factor (PDGF)-receptor binding, and intracellular Ca2+ signaling of Swiss 3T3 fibroblasts was studied. Some of the azo dyes were more potent inhibitors of PDGF binding than was suramin. The concentration giving 50% inhibition (IC50) of PDGF binding was 0.5 microM for the most potent azo dye as compared with 10 microM for suramin. The azo dyes were generally more potent inhibitors of nonmitochondrial Ca2+ uptake and of inositol(1,4,5)trisphosphate-mediated Ca2+ release in permeabilized Swiss 3T3 cells than was suramin, and they were more potent inhibitors of PDGF-induced Ca2+ signaling in intact Swiss 3T3 cells. The azo dyes were only as effective as or less effective than suramin in inhibiting the growth of Swiss 3T3 cells, with IC50 values of between 74 and 361 microM being noted for the dyes as compared with 70 microM for suramin. The difference between the growth-inhibitory activity of the azo dyes and that of suramin could not be explained by metabolism of the compounds, which was not detectable in either Swiss 3T3 cells or human liver slice preparations. The results suggest that suramin and some of the azo dyes have actions on cell growth in addition to inhibition of growth factor binding and of Ca2+ signaling.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464160     DOI: 10.1007/bf00685552

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  36 in total

1.  Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.

Authors:  G Powis; K L See; K S Santone; D C Melder; E M Hodnett
Journal:  Biochem Pharmacol       Date:  1987-08-01       Impact factor: 5.858

Review 2.  Recent insights in phosphatidylinositol signaling.

Authors:  P W Majerus; T S Ross; T W Cunningham; K K Caldwell; A B Jefferson; V S Bansal
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

3.  Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses.

Authors:  E De Clercq
Journal:  Cancer Lett       Date:  1979-11       Impact factor: 8.679

4.  Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes.

Authors:  C W Mahoney; A Azzi; K P Huang
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

5.  An increase in intracellular free Ca2+ associated with serum-free growth stimulation of Swiss 3T3 fibroblasts by epidermal growth factor in the presence of bradykinin.

Authors:  R Olsen; K Santone; D Melder; S G Oakes; R Abraham; G Powis
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

Review 6.  Metabolism of azo dyes: implication for detoxication and activation.

Authors:  W G Levine
Journal:  Drug Metab Rev       Date:  1991       Impact factor: 4.518

7.  Metabolism and covalent binding of [14C]toluene by human and rat liver microsomal fractions and liver slices.

Authors:  D E Chapman; T J Moore; S R Michener; G Powis
Journal:  Drug Metab Dispos       Date:  1990 Nov-Dec       Impact factor: 3.922

8.  Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.

Authors:  R J Coffey; E B Leof; G D Shipley; H L Moses
Journal:  J Cell Physiol       Date:  1987-07       Impact factor: 6.384

9.  High molecular weight dextran sulfate inhibits intracellular Ca2+ release and decreases growth factor-induced increases in intracellular free Ca2+ in Swiss 3T3 fibroblasts.

Authors:  M J Seewald; J J Schlager; R A Olsen; D C Melder; G Powis
Journal:  Cancer Commun       Date:  1989

10.  Suramin binds to platelet-derived growth factor and inhibits its biological activity.

Authors:  M Hosang
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

View more
  3 in total

1.  Inhibition of growth factor binding and intracellular Ca2+ signalling by dextran sulfates of different sizes and degrees of sulfation.

Authors:  G Powis; M Seewald; M Hoke
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Helianthin induces antiproliferative effect on human glioblastoma cells in vitro.

Authors:  Oana Alexandru; Laura Dragutescu; Ligia Tataranu; Vasile Ciubotaru; Ani Sevastre; Ada Maria Georgescu; Oana Purcaru; Suzana Danoiu; L Magnus Bäcklund; Anica Dricu
Journal:  J Neurooncol       Date:  2010-07-16       Impact factor: 4.130

Review 3.  Inhibitors of phosphatidylinositol signalling as antiproliferative agents.

Authors:  G Powis; D Phil
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.